| __timestamp | ADMA Biologics, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 15746000 |
| Thursday, January 1, 2015 | 6745968 | 13392000 |
| Friday, January 1, 2016 | 8494742 | 9290000 |
| Sunday, January 1, 2017 | 18092835 | 7672000 |
| Monday, January 1, 2018 | 22502922 | 15293000 |
| Tuesday, January 1, 2019 | 25910757 | 22648000 |
| Wednesday, January 1, 2020 | 35050817 | 21864000 |
| Friday, January 1, 2021 | 42896889 | 37318000 |
| Saturday, January 1, 2022 | 52458024 | 48130000 |
| Sunday, January 1, 2023 | 59020000 | 108146000 |
Unleashing insights
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. from 2014 to 2023. Over this period, Madrigal Pharmaceuticals saw a staggering 587% increase in SG&A expenses, peaking in 2023. Meanwhile, ADMA Biologics experienced a 1,124% rise, highlighting their aggressive expansion strategy.
In 2023, Madrigal's SG&A expenses were nearly double those of ADMA, reflecting their significant investment in administrative and sales functions. This trend underscores the strategic differences between the two companies, with Madrigal focusing on scaling operations and ADMA on rapid growth. Understanding these financial dynamics offers valuable insights into the operational priorities and market strategies of these biotech firms.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.